FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Plaxe

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Kristy K Ward; Angelica M Roncancio; Steven C Plaxe
Women with gynecologic malignancies have a greater incidence of suicide than women with other cancer types.
Kristy K Ward; Edwin A Alvarez; Michael T McHale; Cheryl C Saenz; Nina R Shah; Steven C Plaxe
Changing demographics of cervical cancer in the United States (1973-2008).
Kristy K Ward; Edwin A Alvarez; Michael T McHale; Cheryl C Saenz; Nina R Shah; Steven C Plaxe
Cardiovascular disease is the leading cause of death among endometrial cancer patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Plaxe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kristy K Ward; Angelica M Roncancio; Steven C Plaxe
Women with gynecologic malignancies have a greater incidence of suicide than women with other cancer types.
Suicide & life-threatening behavior 2013;43(1):109-15.
2012: Kristy K Ward; Edwin A Alvarez; Michael T McHale; Cheryl C Saenz; Nina R Shah; Steven C Plaxe
Changing demographics of cervical cancer in the United States (1973-2008).
Gynecologic oncology 2012;126(3):330-3.
2012: Kristy K Ward; Edwin A Alvarez; Michael T McHale; Cheryl C Saenz; Nina R Shah; Steven C Plaxe
Cardiovascular disease is the leading cause of death among endometrial cancer patients.
Gynecologic oncology 2012;126(2):176-9.
2011: Mariah R Baughn; Steven C Plaxe; Noel Weidner
Primary squamous carcinoma of the ovary likely arising from a monodermal cystic mucinous teratoma.
Annals of diagnostic pathology 2011;15(6):446-9.
2011: Ann M Ponsford Tipps; Steven C Plaxe; Noel Weidner
Endometrioid carcinoma with a low-grade spindle cell component: a tumor resembling an adnexal tumor of probable Wolffian origin.
Annals of diagnostic pathology 2011;15(5):376-81.
2008: Steven C Plaxe; Sandra E Brooks; Chunquiao Tian; Jeffrey D Bloss; David H Moore; Harry J Long
Influence of race on tolerance of platinum-based chemotherapy and clinical outcomes in women with advanced and recurrent cervical cancer: a pooled analysis of 3 Gynecologic Oncology Group studies.
American journal of obstetrics and gynecology 2008;199(5):539.e1-6.
2008: Steven C Plaxe
Epidemiology of low-grade serous ovarian cancer.
American journal of obstetrics and gynecology 2008;198(4):459.e1-8; discussion 459.e8-9.
2002: Steven C Plaxe; John A Blessing; George Olt; Nader Husseinzadah; Samuel S Lentz; Koen DeGeest; Fidel A Valea
A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Cancer chemotherapy and pharmacology 2002;50(2):151-4.
2002: Steven C Plaxe; John A Blessing; Mark A Morgan; John Carlson
Phase II trial of pyrazoloacridine in recurrent platinum-resistant ovarian cancer: a Gynecologic Oncology Group study.
American journal of clinical oncology 2002;25(1):45-7.
2002: Steven C Plaxe; John A Blessing; Nader Husseinzadeh; Kenneth D Webster; Janet S Rader; Charles J Dunton
Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Gynecologic oncology 2002;84(2):241-4.
2002: Steven C Plaxe; John A Blessing; Michael A Bookman; William T Creasman
Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.
Gynecologic oncology 2002;84(1):32-5.
2001: Steven C Plaxe; John A Blessing; Joseph Lucci; JA Hurteau
A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study.
Investigational new drugs 2001;19(1):77-80.
2000: Maida M de las Alas; RD Christen; DP Gately; D E Weiner; K Benbatoul; S Kirmani; H R D'Agostino; Steven C Plaxe; D Darrah; EF McClay; Stefan Aebi; Stephen B Howell; Gerrit Los
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel.
Cancer chemotherapy and pharmacology 2000;45(5):381-8.
1999: Steven C Plaxe; S L Saltzstein
Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening.
Gynecologic oncology 1999;75(1):55-61.
1999: Stefan Aebi; T W Schnider; Gerrit Los; D D Heath; D Darrah; S Kirmani; EF McClay; HB D'Agostino; Steven C Plaxe; D Fink; Maida M de las Alas; Stephen B Howell; RD Christen
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel.
Cancer chemotherapy and pharmacology 1999;44(3):259-65.
1998: Steven C Plaxe; R D Christen; J O'Quigley; P S Braly; J L Freddo; EF McClay; D Heath; Stephen B Howell
Phase I and pharmacokinetic study of intraperitoneal topotecan.
Investigational new drugs 1998;16(2):147-53.
1997: Steven C Plaxe; S L Saltzstein
Impact of ethnicity on the incidence of high-risk endometrial carcinoma.
Gynecologic oncology 1997;65(1):8-12.
1995: EF McClay; P D Braly; S Kirmani; Steven C Plaxe; S Kim; M E McClay; L Wilgus; Stephen B Howell
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma.
American journal of clinical oncology 1995;18(1):23-6.
1994: Steven C Plaxe; J Freddo; S Kim; S Kirmani; EF McClay; R Christen; P Braly; S Howell
Phase I trial of cisplatin in combination with glutathione.
Gynecologic oncology 1994;55(1):82-6.
1994: S Kirmani; P S Braly; EF McClay; S L Saltzstein; Steven C Plaxe; S Kim; C Cates; Stephen B Howell
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer.
Gynecologic oncology 1994;54(3):338-44.
1994: EF McClay; P D Braly; S Kirmani; Steven C Plaxe; M E McClay; L Wilgus; S Kim; Stephen B Howell
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies.
Cancer 1994;74(2):664-9.
1994: Steven C Plaxe
Ovarian cancer.
Medical Section proceedings : the ... annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting 1994;():121-8.
1993: RD Christen; EF McClay; Steven C Plaxe; Samuel S C Yen; S Kim; S Kirmani; L L Wilgus; D D Heath; D R Shalinsky; J L Freddo
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2417-26.
1993: EF McClay; R Goel; P Andrews; S Gorelick; S Kirmani; S Kim; P Braly; Steven C Plaxe; S Hoff; J Alcaraz
A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
British journal of cancer 1993;68(4):783-8.
1993: Steven C Plaxe; P S Braly; J L Freddo; EF McClay; RD Christen; S Kirmani; S Kim; D Heath; Stephen B Howell
Phase I and pharmacokinetic study of intraperitoneal ormaplatin.
Gynecologic oncology 1993;51(1):72-7.
1993: A Bonetti; Stephen B Howell; EF McClay; S Kirmani; R Goel; Steven C Plaxe; P Braly; S Kim
High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensity.
Gynecologic oncology 1993;49(3):318-24.
1993: Steven C Plaxe; P S Braly; J L Freddo; EF McClay; S Kirmani; S B Howell
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer.
Obstetrics and gynecology 1993;81(5 ( Pt 1)):651-4.
1993: S Kim; Stephen B Howell; EF McClay; S Kirmani; R Goel; Steven C Plaxe; P Braly; A Bonetti
Dose intensification of cisplatin chemotherapy through biweekly administration.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(3):221-7.
1993: Steven C Plaxe; P S Braly; PR Dottino
A simplified approach to superficial inguinal dissection with sparing of the saphenous vein in patients with carcinoma of the vulva.
Surgery, gynecology & obstetrics 1993;176(3):295-6.
1993: Steven C Plaxe; PR Dottino; C J Cohen
Gynecologic malignancy presenting as hernia.
American family physician 1993;47(1):51, 54, 57.
1992: R Goel; EF McClay; S Kirmani; S Kim; P F Braly; Steven C Plaxe; J Alcaraz; P A Andrews; B Reichman; M Markman
Pharmacokinetic study of intraperitoneal streptozotocin.
Clinical and investigative medicine. Médecine clinique et experimentale 1992;15(5):420-6.
1991: PR Dottino; Steven C Plaxe; Carmel J Cohen
A phase II trial of adjuvant cisplatin and doxorubicin in stage I epithelial ovarian cancer.
Gynecologic oncology 1991;43(3):203-5.
1991: Seiji Isonishi; S Kirmani; S Kim; Steven C Plaxe; P S Braly; EF McClay; Stephen B Howell
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.
Journal of the National Cancer Institute 1991;83(9):621-6.
1991: Stephen B Howell; S Kirmani; EF McClay; S Kim; P Braly; Steven C Plaxe
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma.
Seminars in oncology 1991;18(1 Suppl 3):5-10.
1991: PR Dottino; Steven C Plaxe; A M Beddoe; Carolyn M Johnston; Carmel J Cohen
Induction chemotherapy followed by radical surgery in cervical cancer.
Gynecologic oncology 1991;40(1):7-11.
1990: Steven C Plaxe; Liane Deligdisch; PR Dottino; C J Cohen
Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma.
Gynecologic oncology 1990;38(3):367-72.
1990: Steven C Plaxe; PR Dottino; Carmel J Cohen
Therapeutic and metabolic effects of high (greater than 1 g/m2) systemic cumulative doses of cis-platinum in patients with ovarian carcinoma.
Gynecologic oncology 1990;37(2):250-3.
1990: Steven C Plaxe; PR Dottino; H M Goodman; Liane Deligdisch; M Idelson; Carmel J Cohen
Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapy.
Gynecologic oncology 1990;37(2):244-9.
1990: Steven C Plaxe; PR Dottino; R Lipsztein; J Dalton; C J Cohen
Clinical features and treatment outcome of patients with epithelial carcinoma of the ovary metastatic to the central nervous system.
Obstetrics and gynecology 1990;75(2):278-81.
1988: Liane Deligdisch; Steven C Plaxe; Carmel J Cohen
Extrauterine pelvic malignant mixed mesodermal tumors. A study of 10 cases with immunohistochemistry.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1988;7(4):361-72.